Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SHSE:600211's Days Inventory is ranked worse than 87.76% of 923
companies
in the Drug Manufacturers industry
Industry Median: 164.38
vs SHSE:600211: 331.64
Inventory Turnover measures how fast the company turns over its inventory within a year.
Tibet Rhodiola Pharmaceutical Holding Co's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.27.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Tibet Rhodiola Pharmaceutical Holding Co's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.26.
Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Tibet Rhodiola Pharmaceutical Holding Co's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Tibet Rhodiola Pharmaceutical Holding Co's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Tibet Rhodiola Pharmaceutical Holding Co Days Inventory Related Terms
Tibet Rhodiola Pharmaceutical Holding Co Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tibet Rhodiola Pharmaceutical Holding Co Days Inventory Chart
Tibet Rhodiola Pharmaceutical Holding Co Annual Data
SHSE:600211 vs ZTS, UTHR: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Tibet Rhodiola Pharmaceutical Holding Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tibet Rhodiola Pharmaceutical Holding Co Days Inventory vs Drug Manufacturers Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211) has a Days Inventory of 332.65 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Tibet Rhodiola Pharmaceutical Holding Co and its competitors. This is 73% above median its historical median of 191.74. Over the past decade, Tibet Rhodiola Pharmaceutical Holding Co's Days Inventory has ranged from 120.88 to 333.79. According to the industry distribution chart, Tibet Rhodiola Pharmaceutical Holding Co ranks #810 out of 923 companies in the Drug Manufacturers industry, placing it in the top 87.8%.
Is Tibet Rhodiola Pharmaceutical Holding Co's Days Inventory too high?
Tibet Rhodiola Pharmaceutical Holding Co's current Days Inventory of 332.65 is 73% above median its 10-year median of 191.74. Over the past 10 years, this metric has ranged from a low of 120.88 to a high of 333.79. The Drug Manufacturers industry median Days Inventory is 164.38. Tibet Rhodiola Pharmaceutical Holding Co's value of 332.65 is 102.4% above this industry median. Based on the distribution chart, Tibet Rhodiola Pharmaceutical Holding Co ranks #810 out of 923 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Tibet Rhodiola Pharmaceutical Holding Co has a GF Score™ of 94/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Tibet Rhodiola Pharmaceutical Holding Co's Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Tibet Rhodiola Pharmaceutical Holding Co ranks #810 out of 923 companies for Days Inventory. This places Tibet Rhodiola Pharmaceutical Holding Co in the lower half of its industry. The industry median Days Inventory is 164.38. Tibet Rhodiola Pharmaceutical Holding Co's value of 332.65 is 102.4% above this benchmark. Historically, Tibet Rhodiola Pharmaceutical Holding Co's own Days Inventory has ranged from 120.88 to 333.79 over the past decade. While the company's 10-year median is 191.74 vs. the industry median of 164.38, Tibet Rhodiola Pharmaceutical Holding Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.38, based on 923 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Tibet Rhodiola Pharmaceutical Holding Co's current Days Inventory of 332.65 is 102.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Tibet Rhodiola Pharmaceutical Holding Co and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tibet Rhodiola Pharmaceutical Holding Co's current Days Inventory is 332.65, which is 73% above median its own 10-year median of 191.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tibet Rhodiola Pharmaceutical Holding Co stock overvalued right now?
Based on GuruFocus' analysis, Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211) is currently considered Fairly Valued. The stock's GF Value™ is ¥40.55, compared to a current price of ¥40.07 — trading 1.2% below its estimated fair value. The current Days Inventory is 332.65, which is 73% above median its 10-year median of 191.74 and 102.4% above the Drug Manufacturers industry median of 164.38. Tibet Rhodiola Pharmaceutical Holding Co's overall GF Score™ is 94/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211), the current Days Inventory is 332.65 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211) Overvalued in 2026?
Based on GuruFocus' analysis, Tibet Rhodiola Pharmaceutical Holding Co stock appears to be undervalued.
The current stock price of ¥40.07 is trading 1.2% below its estimated GF Value™ of ¥40.55.
GuruFocus considers Tibet Rhodiola Pharmaceutical Holding Co to be Fairly Valued.
Key valuation signals for SHSE:600211:
Days Inventory: 332.65 (73% above median its 10-year median of 191.74)
GF Value™: ¥40.55 vs. price of ¥40.07 (1.2% below fair value)
Industry Position: 102.4% above the Drug Manufacturers median (#810 of 923)
No single metric tells the full story. See the SHSE:600211 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tibet Rhodiola Pharmaceutical Holding Co Business Description
Tibet Rhodiola Pharmaceutical Holding Co is a pharmaceutical company engaged in the production and sales of capsules, biological agents, granules, and coatings. The company's products cover biopharmaceuticals, Tibetan medicine, traditional Chinese medicine, and chemical drugs, involving fields such as cardiovascular and cerebrovascular diseases, hepatobiliary diseases, orthopedic pain relief, rheumatism, and cold medicines.
94GF Score
Get the complete analysis for SHSE:600211
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600211 has been successfully added to your 
